Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideABTAbbott Laboratories
FinDog View：Neutral
ISRGIntuitive Surgical
FinDog View：Bullish
| Metric | ABT | ISRG |
|---|
| Close | 106.20 | 432.01 |
| Market Cap | $184B | $151B |
| 1M | +7.46% | +6.24% |
| P/E (TTM) | 39.1 | 52.6 |
| Forward P/E | 17.6 | 34.3 |
| P/E 5-Yr Percentile | 99 | 15 |
| P/S | 3.8 | 13.4 |
| P/B | 3.6 | 9.7 |
| Dividend Yield | 1.98% | — |
| Latest Quarter Revenue | $11.2B | $3.0B |
| Revenue YoY | +7.8% | +21.7% |
| Gross Margin | 56.2% | 68.4% |
| Latest Quarter EPS | 0.61 | 1.49 |
| Avg Post-Earnings Move | ±1.6% | ±6.3% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.71% | 3.05% |
| 90-Day Net Insider Buying | −$46.9M | −$16.9M |
ABT · Revenue, Last 8 Quarters ($B)
ISRG · Revenue, Last 8 Quarters ($B)
